Sturiale Alessandro, Dowais Raad, Fabiani Bernardina, Menconi Claudia, Porzio Felipe Celedon, Coli Virginia, Naldini Gabriele
Proctology and Pelvic Floor Clinical Centre, Cisanello University Hospital, Pisa, Italy.
Department of General and Colorectal Surgery, Yarmouk University, Irbid, Jordan.
Ann Coloproctol. 2023 Feb;39(1):11-16. doi: 10.3393/ac.2020.00227.0032. Epub 2021 Jul 29.
The study aimed to assess the long-term results of the stapled hemorrhoidopexy (SH) using high-volume devices equipped with innovative technology, evaluating recurrence rate, complications rate, and patients' satisfaction.
All the patients who underwent SH using high-volume devices (TST Starr plus, Touchstone International Medical Science Corp., Ltd.) for II to IV symptomatic hemorrhoidal disease from November 2012 to December 2014 were enrolled. Between December 2019 and January 2020, all of them were phone called to come to undergo a proctological reevaluation and asked to fill some questionnaires about hemorrhoidal prolapse recurrence, symptoms recurrence, and surgery satisfaction.
Fifty-nine patients with a mean age of 47 years completely answered the questionnaires. Twenty-two of them accepted to come to undergo a proctological reevaluation while 27 preferred to answer only by phone due to their referred wellbeing. The median follow-up was 70.5 months (range, 60-84 months). The recurrence rate was 5.1% with a mean satisfaction level after surgery was 9.1 (range, 0-10) and 84.7% of patients whose satisfaction scored ≥8. The mean value of Cleveland Global Quality of Life assessment was 0.79 (range, 0.71-0.93). There were no cases of new onset of impaired anal continence after surgery.
The new generation high-volume devices to perform SH resulted to be safe and effective for II to IV degree hemorrhoidal prolapse leading to a lower long-term recurrence rate with an evident reduction of postoperative complications in comparison with the low-volume SH.
本研究旨在评估使用配备创新技术的大容量器械进行吻合器痔上黏膜环切术（SH）的长期效果，评估复发率、并发症发生率及患者满意度。
纳入2012年11月至2014年12月期间使用大容量器械（TST Starr plus，通世泰国际医学科技有限公司）对Ⅱ至Ⅳ度症状性痔病进行SH手术的所有患者。在2019年12月至2020年1月期间，给所有患者打电话让其前来接受直肠病学重新评估，并要求填写一些关于痔脱垂复发、症状复发及手术满意度的问卷。
59名平均年龄为47岁的患者完整回答了问卷。其中22人接受前来进行直肠病学重新评估，27人因自述身体状况良好而更愿意仅通过电话回答。中位随访时间为70.5个月（范围60 - 84个月）。复发率为5.1%，术后平均满意度为9.1（范围0 - 10），84.7%的患者满意度评分≥8。克利夫兰全球生活质量评估的平均值为0.79（范围0.71 - 0.93）。术后无新出现肛门失禁受损的病例。
新一代用于进行SH的大容量器械对Ⅱ至Ⅳ度痔脱垂安全有效，与小容量SH相比，长期复发率更低，术后并发症明显减少。
